Dyne Therapeutics, Inc. (DYN) short interest & options flow
NASDAQDyne Therapeutics enters the final stretch before its August 10 earnings report with the stock up 9% on the week — yet the defensive positioning that defined last week's note has shifted rather than resolved. The most notable change from the July 22 article is in options. The put/call ratio has eased from its 52-week high of 5.26 on Thursday to 4.70 on Tuesday, still well above the…
- Market cap
- $3.37B
- Next earnings
- 26 Feb 2027
Key data as of 12 Nov 2026

DYN news and analysis
RSSNo long-form analysis yet for DYN. Pulse alerts and the live data picture are available on ORTEX.
Open DYN on ORTEX →Want the live picture for DYN?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for DYN — free to start on ORTEX.
Sign up for free →Open DYN on ORTEX